Page last updated: 2024-09-05

regadenoson and Cardio-Renal Syndrome

regadenoson has been researched along with Cardio-Renal Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ali, A; Campagnoli, T; Doukky, R; Fughhi, I; Wassouf, M	1

Other Studies

1 other study(ies) available for regadenoson and Cardio-Renal Syndrome

Article	Year
The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:1 Topics: Age Distribution; Cardio-Renal Syndrome; Chicago; Comorbidity; Coronary Artery Disease; Death, Sudden, Cardiac; Exercise Test; Female; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sex Distribution; Single-Blind Method; Survival Rate; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents	2017

Article

Year

The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:1

Topics: Age Distribution; Cardio-Renal Syndrome; Chicago; Comorbidity; Coronary Artery Disease; Death, Sudden, Cardiac; Exercise Test; Female; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sex Distribution; Single-Blind Method; Survival Rate; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2017